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Abstract.  The Golgi complex is composed of at least 
four distinct compartments,  termed the cis-, medial, 
and trans-Golgi  cisternae and the trans-Golgi  network 
(TGN).  It has recently been reported that the organiza- 
tion of the Golgi complex is disrupted in cells treated 
with the fungal metabolite, brefeldin-A.  Under these 
conditions,  it was shown that resident enzymes of the 
cis-, medial,  and trans-Golgi  return to the ER. We re- 
port here that 300-kD mannose 6-phosphate receptors, 
when pulse-labeled within the ER of brefeldin-A- 
treated cells, acquired numerous N-linked galactose 
residues with a half time of approximately 2 h,  as 
measured by their ability to bind to RCA-I lectin 
affinity columns.  In contrast, Limax flavus lectin chro- 
matography revealed that <10%  of these receptors ac- 
quired sialic acid after 8 h in brefeldin-A.  Two lines 
of evidence suggested that proteins within and beyond 
the TGN did not return to the ER in the presence of 
brefeldin-A.  First,  the majority of 300-kD mannose 
6-phosphate receptors present in the TGN and endo- 
somes did not return to the ER after up to 6 h in 
brefeldin-A, as determined by their failure to contact 
galactosyltransferase that had relocated there. 
Moreover, although marmose 6-phosphate receptors 
did not acquire sialic acid when present in the ER of 
brefeldin-A-treated cells, they were readily sialylated 
when labeled at the cell surface and transported to the 
TGN.  These experiments indicate that galactosyltrans- 
ferase, a trans-Golgi  enzyme, returns to the endoplas- 
mic reticulum in the presence of brefeldin-A, while 
the bulk of sialyltransferase,  a resident of the TGN, 
does not.  Our findings support the proposal that the 
TGN is a distinct,  fourth compartment of the Golgi 
apparatus that is insensitive to brefeldin-A. 
B 
IOCHEMICAL  fractionation  experiments and the immu- 
nocytochemical localization of specific glycosyltrans- 
ferases and their products have led to the notion that 
the Golgi complex is divided into at least three distinct  sub- 
comparmaents (11, 21, 23, 27). The first compartment,  termed 
the cis-Golgi, is thought to house N-acetylglucosamine  (Glc- 
NAc)t-l-phosphodiester  ot-N-acetylglucosaminidase  (18), an 
enzyme involved in the construction of mannose 6-phosphate 
(man6P) residues on lysosomal enzyme oligosaccharide side 
chains. The medial Golgi houses GlcNAc transferase  I (12), 
and galactosyltransferase  is located predominantly in trans- 
Golgi cisternae (37).  Since proteins pass through  the Golgi 
by a series of vesicular transfers  (39)  from the cis- to the 
medial to the trans-Golgi  (3, 42), the assembly of N-linked 
oligosaccharide chains  is regulated  by the order in which 
proteins gain access to particular mannosidases and glycosyl- 
transferases  (27). Beyond oligosaccharide assembly, the sig- 
nificance of Golgi compartmentation is not fully understood. 
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It has recently been reported that the organization  of the 
Golgi stack is severely altered in cells treated with the fungal 
metabolite,  brefeldin-A  (BFA).  Individual  Golgi cisternae 
become difficult  to identify by immunocytochemistry (13, 
28, 45), and the export of proteins from the ER is blocked 
(13, 31, 32).  Remarkably,  enzymes that normally reside in 
the Golgi complex are relocated to the ER, where they act 
upon proteins accumulated there (9, 28, 29). Furthermore, 
the redistribution  of Golgi enzymes to the ER is entirely re- 
versible;  after removal of BFA, the Golgi stack reassembles 
and transport through the secretory pathway resumes (9, 13, 
28, 29, 32). 
Lippincott-Schwartz  et al. (28) and Doms et al.  (9) noted 
that proteins retained within the ER of BFA-treated cells ap- 
pear not to acquire sialic acid residues, despite the conver- 
sion of their N-linked  oligosaccharides from high-mannose 
to complex-type structures.  The lack of sialic acid addition 
suggested that enzymes in the trans-Golgi and/or trans-Golgi 
network (TGN)  might  not relocate to the ER,  unlike  en- 
zymes that reside in earlier Golgi compartments.  To further 
investigate this potential  distinction  between early and late 
Golgi subcompartments,  we set up a sensitive assay to test 
whether galactosyltransferase  and sialyltransferase  return to 
the ER in BFA-treated CHO cells. Consistent with analyses 
of other glycoproteins (9, 28), we found that mannose 6-phos- 
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treated cells, readily acquired N-linked galactose, yet only 
rarely acquired sialic acid residues. We show here that the 
failure of proteins to acquire sialic acid is most likely due 
to a failure of sialyltransferase to relocate to the ER, rather 
than an inability of the enzyme to act within the ER. Our 
results indicate that unlike the cis-, medial, and trans-Golgi 
cisternae, the TGN is insensitive to BFA action. 
Materials and Methods 
Materials 
Brefeldin-A was either the generous gift of Dr. R. Klausner (National Insti- 
tutes of Health)  or purchased from Epicenter Bioteclmolngy  (Madison, 
WI). RCA-I agarose, 3-[(3-cholamidopmpyl)dimethylammonio]-l-propane- 
sulfonate (CHAPS), galactosyltransferase,  ~-galactosidase,  and deoxyman- 
nojirimycin (dMM) were from Sigma Chemical Co. (St. Louis, MO). Pen- 
tamannosyl phospbate-Sepharose and L/maxflovus slug lectin-Aifigel were 
prepared as described (17, 34). 
Cells 
Chinese hamster ovary (CHO) clone 13, clone 15B, and clone 1021 cells 
were originally obtained from Dr.  S.  Kornfeld  by Dr.  J.  Rothman,  who 
provided them to our laboratory.  CHO clone 13 cells cannot translocate 
UDP-galactose  into the Golgi and display  an apparent defect  in galac- 
tosyltransferase  (6); CHO 15B cells lack GlcNAc transferase I activity (20); 
clone 1021 cells lack CMP-sialic  acid translocase activity, and thus cannot 
add sialic acid to oligosaccbaride chains (6, 8). CHO clone 15B and clone 
1021 cell lines were grown as monolayers in c~MEM containing 7.5% fetal 
calf serum and antibiotics. CHO wild-type and clone 13 cells were grown 
in suspension culture in the same media. 
Metabolic Labeling 
Cells were labeled with [35S]methionine and cysteine  (Translabel;  Amer- 
sham Corp., Arlington Heights,  IL) at 0.1 mCi/ml in aMEM lacking cys- 
teine and methionine  but containing 10% dialyzed FCS. Chase periods were 
initiated by washing cells twice in TD (25 mM "Iris C1, pH 7.4, 5.4 mM 
KC1, 137 mM NaC1, 0.3 mM NazHPO4), followed by addition of complete 
media. After the times indicated, cells were washed once in ice-cold  TD 
and lysed with 1.0 ml RIPA buffer (50 mM Tris HCI pH 7.2, 0.15 M NaCI, 
1% Triton X-100, 1% deoxyeholate,  0,1% SDS, and 0.1% gelatin).  Lysates 
were centrifuged at 330000 g for 10 rain in a centrifuge (model TL-100; 
Beckman Instruments, Fullerton, CA). Suspension cells were labeled at a 
density of ~2 x  l(P/ml. 
Lectin Chromatography 
300-kD mannose 6-phosphate receptors were isolated from cell  extracts by 
pentamannosyl-phosphate Sepharose chromatography (34). Receptors  iso- 
lated from the equivalent  of ,,~125 t~g cell extract were then incubated with 
100/~1 RCA-I agarose in a total volume of I ml, 50 mM Hells pH 7.5, 150 
mM NaCI,  0.5%  CHAPS, 5 mM ~-glycerophosphate  for 30 min at room 
temllrature. The slurry was poured into a column, washed with 3 ml of 
the same buffer  (except that it contained 0.05%  Triton X-100 instead of 
CHAPS), and ehited with 1 ml of the former buffer containing 0.1 M galac- 
tose. Slug lectin chromatography was carried out according to Goda and 
Pfeffer (17). Samples were then precipitated in TCA, electrophoresed  in 6% 
SDS polyacrylamide  gels,  dried, and autoradiographed as previously  de- 
scribed (34). 
Cycloheximide Treatment 
CHO clone 1021 cells were metabolically labeled for 60 min in the presence 
of 10 ttg/rnl BFA and then chased for 4 h in the presence or absence of 100 
~tg/ml cycloheximide, shown previously to block protein synthesis by 98 % 
(34).  Samples  were then analyzed as described in Fig.  I and above. 
Surface Labeling of CHO Clone 13 Cells and 
Glycopeptide  Analysis 
Cell surface man6P receptor oligosaccharides  were labeled with UDP- 
[3H]Gal (Amersham Corp.) and galactosyltransferase  according to Duncan 
and Kornfeld (10). Cells were then incubated at 37°C (in 100 ml suspension 
culture)  for 0 or 6 h in the presence or absence of 10 ttg/rnl BFA. Man6P 
receptors were isolated by pentamannosyl phospbate-Sepharose chroma- 
tography (34). Purified receptors were digested with pmnase (CalBiochem- 
Behring  Corp.,  La  Jolla, CA), and the  resulting  glycollptides  were  subjected 
to jack bean/5-galactosidase  digestion and Sephadex (}-25 chromatography 
to assess  sialic acid acquisition (10). 
Other Techniques 
Protein was determined according to the method of Bradford (5) using BSA 
as standard. Autoradiograms were quantified using a densitometer (model 
300A; Molecular Dynamics, Sunnyvale, CA). Neuraminidase treatment of 
man6P receptors was carried out using Arthrobacter ureafaciens neuramini- 
dase as described (17). 
Results 
If cells are treated with 10/~g/ml BFA, proteins within the 
ER acquire endoglycosidase H-resistant oligosaccharides (9, 
28). Since resistance to endoglycosidase H reflects the con- 
certed action of  the medial Golgi enzymes, GlcNAc transfer- 
ase I and Golgi mannosidase II (27), these data suggest that 
resident enzymes of the medial Golgi return to the ER upon 
BFA treatment. Indeed, the redistribution of mannosidase II 
has been  shown directly (28).  We tested whether galac- 
tosyltransferase, a trans-Golgi enzyme (37), and sialyltrans- 
ferase, an enzyme localized to both the trans-Golgi and the 
TGN (38; see also reference 2), also return to the ER in the 
presence of BFA. 
The 300-kD man6P receptor was used as a marker for the 
action of galactosyl- and sialyltransferases. This receptor 
provides a sensitive means to detect glycosyltransferase ac- 
tion, since it contains 19 potential N-linked oligosaccharide 
addition sites (30)  and is highly glycosylated. The experi- 
ment was carried out as follows.  CHO cells were labeled 
with [35S]methionlne and cysteine for 60 rain to label newly 
synthesized rnan6P receptors. At this time, labeled man6P 
receptors reside in the ER, since these receptors require up 
to 3 h to fold and be completely exported from this compart- 
ment (19, 40). Cells were then chased for various times in 
the presence of BFA, and the potential acquisition of galac- 
tose residues was determined by affinity chromatography of 
isolated  man6P  receptors  on  columns  of the  galactose- 
specific lectin, RCA-I (1). To further increase the sensitivity 
of the assay, we used CHO clone 1021 cells that lack appar- 
ent sialyltransferase activity (6, 8). In these cells, any added 
galactose residues will be present at the termini of N-linked 
oligosaccharides and fully accessible for optimal lectin bind- 
ing (1). 
Fig. I (top)  shows the results  obtained from such an ex- 
periment. Man6P receptors  isolated  from cells  immediately 
after  the labeling  period should not have contained galac- 
rose. As expected, none of the man6P receptors bound to 
RCA-I agarose; all were recovered in the flowthrough frac- 
tion. In contrast,  with increasing  times of BFA treatment, 
man6P receptors acquired the ability  to be retained  on an 
RCA-I column, and could be eluted  from such columns with 
galactose. Quantitative  analysis  of this  experiment (Fig. I, 
bottom) showed that half of the man6P receptors gained the 
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treated  cells.  (Top) CHO  clone  1021 cells  were  labeled  with 
[35S]methionine and  cysteine  for 60  rain  in the  presence  of 10 
#g/ml BFA, and then chased in growth media containing BFA for 
the indicated times. Man6P receptors were then isolated by affinity 
chromatography  and  applied  to  RCA-I agarose.  Fractions  that 
flowed through the column (left) or were eluted with 0.1 M galac- 
tose (right)  were  subjected  to SDS-PAGE and  autoradiography. 
(Bottom) Kinetics of galactose addition in the presence or absence 
of BFA. Data points were obtained  by densitometric  scanning of 
the autoradiogram  shown or from another obtained  in an experi- 
ment in which BFA was omitted from the labeling and chase media. 
Triangles,  +BFA;  squares,  -BFA. 
capacity to bind RCA-I agarose within '~2 h. This was some- 
what slower than the rate observed in the absence of BFA 
(hr~ =  80 rain). A control experiment showed that galactose 
addition was not due to the action of newly synthesized ga- 
lactosyltransferase, also accumulated in the ER, since cyclo- 
beximide had essentially no effect on the extent of galactose 
addition (not shown). 
RCA-I lectin binds to galactose residues present on both 
N- and O-linked oligosaccharides  (1). To determine if the 
binding observed was due to the addition of N-linked galac- 
tose residues,  we carried out  a  parallel  experiment using 
CHO clone  15B  cells that lack the  activity of the  medial 
Golgi enzyme,  GlcNAc transferase I  (20).  In these  cells, 
Figure 2. Man6P receptors fail to 
acquire galactose in cells lacking 
GIcNAc transferase I. CHO clone 
15B cells were metabolically  la- 
beled for 60 rain in the presence 
or absence of 10 ~,g/ml BFA and 
then  chased  in growth media  in 
the presence  or absence  of BFA 
for 3 h. Man6P receptors were then isolated by affinity chromatog- 
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Figure 3. Man6P receptors acquire limited sialic acid within the ER 
of BFA-treated cells.  CHO wild type cells were metabolically la- 
beled for 60 rain in the presence or absence of 10 #g/ml BFA and 
then chased in the presence  or absence of BFA for the indicated 
times. Fresh BFA was added after 4 h to ensure its continued action 
(13). Man6P receptors were then isolated by affinity chromatogra- 
phy and applied to slug lectin-Affigel columns. The percentage of 
man6P receptors eluted from such columns was determined by den- 
sitometric  scanning of autoradiograms  as in Fig.  1. 
galactose  cannot  be  added  to  N-linked  oligosaccharides 
because  the  oligosaccharides  lack  penultimate  GlcNAc. 
O-linked sugar assembly is unaffected,  since the O-linked 
sugar acceptor would be GalNAc, rather than GlcNAc, As 
shown in Fig. 2, man6P receptors isolated from CHO clone 
15B cells, incubated in the presence or absence of BFA for 
3 h, did not bind to RCA-I columns. Failure of these recep- 
tors to bind to RCA-I columns was not due to the presence 
of sialic  acid-blocked,  O-linked  gaiactose,  because  neur- 
aminidase treatment did not increase the RCA-I binding ca- 
pacity of the isolated receptors (not shown).  We conclude 
that man6P receptors within the ER acquire N-linked galac- 
tose in BFA-treated CHO cells. This is consistent with recent 
results of Lippincott-Schwartz et al.  (29) who used indirect 
immunofluorescence  to  show  the  essentially  quantitative 
redistribution  of galactosyltransferase to  the  ER  in  BFA- 
treated cells. 
The Fate of Sialyitransferase in the Presence of BFA 
Sialic  acid  addition  was monitored  in  BFA-treated,  CHO 
wild-type cells, using the sialic acid-specific lectin from the 
slug,  L/max flavus.  Fig.  3  shows the  kinetics  with  which 
man6P receptors acquired the capacity to bind to slug lectin 
columns and be eluted by excess sialic acid. In the absence 
of BFA, man6P receptors acquired sialic acid during their 
transit through the Golgi complex. Sialic acid addition was 
extensive after 2 h of chase, and by 4 h, 66 % of newly synthe- 
sized man6P receptors had acquired the ability to bind to 
slug lectin-Afligel, as we have previously shown (17).  In the 
presence of BFA, <10% of total man6P receptor molecules 
bound to slug lectin-Atfigel after 8 h of incubation (Fig. 3). 
This  small amount of sialic  acid  addition  was not  due to 
newly synthesized sialyltransferase because it was also ob- 
served in ~e presence of cycloheximide (not shown).  The 
electrophoretic mobility of the sialic acid-containing man6P 
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Figure 4.  Gel filtration analysis of man6P receptor resialylation. 
CHO  clone  13  cells  were  surface  labeled  with  UDP-[3H]galac  - 
tose  and  galactosyltransferase and  then  harvested  immediately 
(open circles) or recultured for 6 h in the presence (triangles) or 
absence (squares) of 10 #g/ral BFA. Man6P receptors were then 
isolated, digested with pronase to prepare glycopeptides, and then 
further digested with/3-galactosidase to cleave [3H]galactose  from 
oligosaccharides that had not received sialic acid. Cleavage prod- 
ucts were resolved by Sephadex G25 chromatography; fractions 
eluting at the void volume (which resisted B-galactosidase  cleavage 
and thus contain sialic acid) are shown. The counts per minute in 
the excluded peak of the control reaction (-BFA) represents 4% of 
the total glycopeptide radioactivity  recovered. In other experi- 
ments, as much as 6% resialylation was observed. 
receptors was faster in BFA-treated cells (not shown), indi- 
cating  that  these  receptors  contained  significantly  fewer 
sialic acid residues than native man6P receptors (17). These 
experiments indicate that either a  very limited amount of 
sialyltransferase activity was present in the ER after 8 h with 
BFA, or alternatively, that the bulk of sialyltransferase activ- 
ity was not redistributed to the ER after 8 h. It is important 
to note that sialyltransferase could have been redistributed 
to the ER in BFA, but might not have been able to function 
there. 
Under normal conditions, man6P receptors recycle from 
the cell surface to the TGN, where they come into contact 
with sialyltransferase (10, 17,  26,  35), but not galactosyl- 
transferase (10). We reasoned that if sialyltransferase failed 
to return to the ER in BFA, this enzyme should remain in 
the TGN, and thus be able to act upon man6P receptors ar- 
riving in that compartment. To test this, we used an experi- 
mental scheme devised by Duncan and Kornfeld (10) to mea- 
sure the transport of man6P receptors from the cell surface 
back to the TGN. The approach uses CHO clone 13 cells, 
in which glycoproteins lack galactose residues and thus can 
be labeled at the plasma membrane using galactosyltransfer- 
ase and UDP-[3H]galactose. The transport of man6P recep- 
tors from the surface to the TGN is then monitored by the 
addition of sialic acid residues to their 3H-labeled oligosac- 
charide side chains (10). 
CHO  clone  13  ceils  were  surface  labeled  at  4°C  and 
warmed for either 0 or 6 h in the presence or absence of  BFA. 
At the end of the incubation, man6P receptors were isolated 
and incubated with pronase to obtain glycopeptides. Sialic 
acid acquisition was then determined by digestion with ~-ga- 
lactosidase and gel filtration chromatography. If an oligosac- 
charide  received sialic  acid,  the  3H-labeled glycopeptide 
would resist/~-galactosidase cleavage and be excluded from 
Sephadex G25. In contrast, digestion of galaetose-terminating 
oligosaccharides would  yield  [3H]galactose,  which would 
be included in the gel filtration column (10). 
When  cells  were  harvested  immediately  after  surface 
labeling, essentially no radioactivity was found in excluded 
column fractions (Fig.  4,  open circles),  as  would be ex- 
pected,  since at this time,  man6P receptor glycopeptides 
should not contain sialic acid. In contrast, sialic acid addi- 
tion was readily observed when cells were recultured for 6 h 
in either the presence or the absence of BFA, as monitored 
by the presence of 3H-glycopeptides  in the void volume frac- 
tion (Fig. 4, solid symbols).  Although the extent of sialyla- 
tion was reproducibly lower ('o65 %) in the presence of BFA 
than in its absence, significant addition of sialic acid was de- 
tected under both conditions. The lower level of sialylation 
observed in BFA may be explained, in part, by a 20 % de- 
crease in the rate of endocytosis observed in the presence of 
10/zg/ml BFA (32).  In summary, this experiment demon- 
strates that at least a large proportion of sialyltransferase ac- 
tivity was present in a compartment reached by cell surface 
man6P receptors in BFA-treated cells.  This compartment 
cannot represent the ER,  since man6P receptors pulse-la- 
beled there were not modified by sialyltransferase (Fig. 3). 
We also used the man6P receptor as an additional marker 
to test whether transient occupants of the TGN return to the 
ER  in  BFA.  CHO  cells  were  metabolically labeled  and 
chased for 4 h to permit newly synthesized man6P receptors 
to achieve their steady-state distribution, primarily in endo- 
somes, the plasma membrane, and the TGN (7, 15, 16, 22). 
The reversible inhibitor of Golgi tx-mannosidase I, dMM 
(4), was included in the labeling and chase media, so that 
man6P receptors within and beyond the TGN would bear 
high-mannose  oligosaccharides.  Next,  dMM  was  washed 
away, and cells were incubated for various lengths of time in 
the presence or absence of BFA.  We then monitored the 
potential galactosylation of man6P receptors that would oc- 
cur if they returned to the ER. 
In the absence of BFA,  high mannose oligosaccharide- 
containing man6P receptors within and beyond the TGN 
would not be expected to gain access to the mannosidases 
and glycosyltransferases that lie proximal to the TGN (10). 
This was verified by isolating man6P receptors after various 
chase intervals and subjecting them to RCA-I chromatogra- 
phy. Fig. 5 (bottom) presents the results of such an experi- 
ment. In the absence of BFA, ,o7% of the mantP receptors 
bound to RCA-I  at time zero, showing that the dMM was 
>90 % effective in inhibiting o~-mannosidase I. After a chase 
period of up to 6 h, there was only a very slight increase 
('o5 %) in the fraction of man6P receptors that bound to an 
RCA-I  column.  These results confirm that the majority of 
CHO cell man6P receptors do not appear to return to the site 
of Golgi o~-mannosidase I (cis/medial Golgi) after transport 
to the TGN (10). 
Fig, 5 (top) shows the results obtained if man6P receptors 
were pulse-labeled either in the ER (squares) or chased to 
compartments beyond the TGN (triangles) in the presence 
of dMM, and then further chased for various times without 
DMM,  but in the presence of BFA.  If the receptors were 
present in the ER, they were efficiently modified by galac- 
tosyltransferase. The rate of galactose addition was slightly 
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Figure 5. The majority of man6P receptors within and beyond the 
TGN do not return to the ER upon BFA addition. CHO clone 1021 
cells were pretreated with 1 mM dMM for 30 min and metaboli- 
cally labeled for 60 min in the presence of dMM. Cells were then 
chased in growth media for 3 h without dMM to allow man6P 
receptors to move out of the ER and into the TGN and late endo- 
somes. Cells were then chased further in the presence (top, trian- 
gles) or absence (bottom, open circles) of 10 #g/ml BFA. Alterna- 
tively, cells were not chased before BFA addition to determine the 
fate of ER-localized  man6P receptors (squares). Galactose acquisi- 
tion was determined as in Fig.  1. 
slower than that observed in the absence of dMM pretreat- 
merit (Fig.  1), probably due to the time required to reverse 
the effect of dMM (4,  10,  33).  On the other hand, if the 
receptors were permitted to pass through the TGN prior to 
the addition of BFA, only a very small increase was detected 
in the amount of man6P receptors containing galactose, even 
after 6 h of incubation (Fig. 5, triangles).  The small increase 
observed ('~8%) was very close to that observed in the ab- 
sence of BFA (Fig. 5, bottom). 
Duncan  and  Kornfeld have  shown  that only  '~10%  of 
man6P receptors labeled at the surface of CHO cells can be 
detected to acquire sialic acid upon their return to the TGN 
after 6 h of reculture (10). In our hands, only ,x,4-6%  of the 
surface-labeled receptor acquired sialic acid after 6 hours 
(Fig. 4). If this value represents the total amount of man6P 
receptor transitting through the TGN in 6 h,  it would be 
difficult  to detect the potential return of such a small quantity 
of  man6P receptors from the TGN to the ER, especially with 
the ,'~2-h lag for galactose addition in that compartment (Fig. 
5). However, results identical to those shown in Fig. 5 were 
obtained using BW5147  ceils,  in  which 40%  of surface- 
labeled man6P receptors return to the TGN in 3 h (10). This 
strongly supports the conclusion that the majority of man6P 
receptors within and beyond the TGN do not return to the 
ER in BFA. 
Discussion 
We have  shown  that the  300-kD  man6P  receptor,  when 
pulse-labeled within the ER of BFA-treated cells, acquires 
numerous N-linked galactose residues and many fewer sialic 
acid residues. These data confirm the findings of Lippincott- 
Schwartz et al. (29) who have used immunofluoresccnce to 
show  that  the  trans-Golgi  enzyme,  galactosyltransferase, 
returns to the ER in the presence of BFA. In addition, our 
experiments suggest that sialyltransferase has a different fate 
in BFA than galactosyltransferase, since the half time for 
sialic acid addition to proteins within the ER (,~60 h) was 
30 times greater than that measured for galactose addition. 
The simplest explanation for these findings would be that 
sialyltransferase, a  component of the  TGN,  is not redis- 
tributed to the ER in BFA, while the trans-Golgi  enzyme, 
galactosyltransferase, is. If true, this supports the proposal 
that the trans-Golgi and TGN are distinct compartments (21). 
The strongest line of evidence supporting the idea that the 
TGN is insensitive to BFA comes from an experiment in 
which we monitored the transport of surface-labeled man6P 
receptors from the surface back to the TGN. Man6P recep- 
tors  were  transported  to  a  compartment  housing  active 
sialyltransferase, whether or not the culture media contained 
BFA.  Moreover, this compartment was not the ER,  since 
man6P receptors pulse-labeled within the ER did not receive 
sialic acid.  Unfortunately, our attempts to localize sialyl- 
transferase by indirect immunofluorescence  under these con- 
ditions were unsuccessful, probably due to the particularly 
low abundance of this enzyme in cultured cells. Nevertheless, 
although not shown directly, it is most likely that the sialyl- 
transferase-containing compartment represents the TGN. 
Ulmer and Palade have recently shown that the protein, 
glycophorin, acquired O-linked sialic acid when present in 
the ER of BFA-treated erythroleukemia cells (45).  However, 
these workers noted that sialylation was not complete, even 
after 6 h. The O-linked oligosaccharides of glycophorin con- 
tain sialic acid both in ~-2,3 linkage to galactose, as well as 
in ot-2,6  linkage to GalNAc (43).  If the GalNAc-specific 
sialyltransferase is  located in  the trans-Golgi  along with 
galactosyltransferase, whereas the Gal-specific sialyltrans- 
ferase is located primarily in the "I'GN, only the GalNAc- 
specific enzyme would redistribute to the ER in BFA. Under 
these conditions, O-linked oligosaccharides would become 
partially sialylated, while N-linked sugars would not. If this 
is correct, the findings of Ulmer and Palade (45) would be 
entirely consistent with those reported here and elsewhere 
(9, 28). 
Several models have been proposed to explain BFA action. 
One possibility is that the target of BFA is associated with 
the ER. By blocking ER export, BFA might be uncovering 
a  vesicular recycling pathway that functions between the 
Golgi and ER (9, 28, 29).  This model could easily explain 
why most Golgi enzymes are redistributed to the ER, if one 
assumes that each cisterna of the Golgi complex communi- 
cates with its proximal neighbor by shuttling transport vesi- 
cles. This model does not explain why TGN components do 
not return to the ER,  because putative shuttling vesicles 
might be expected to move between the TGN and trans-Golgi 
as  frequently as they traverse between trans-  and medial 
Golgi cisternae. If the target of BFA is indeed the ER, our 
data would  suggest that transport  between the  TGN and 
trans-Golgi cisternae differs significantly from transport be- 
tween more proximal Golgi cisternae. 
Another possibility is that BFA acts on the Golgi complex 
and interferes with the mechanism whereby Golgi compart- 
mentation is maintained (9, 28, 29).  This model would re- 
Chege and Pf¢ffer Brefeldin-A Distinguishes trans-Golgi from the TGN  897 quire that cis-, medial and trans-Golgi  cisternae be related 
by a common compartmentation machinery that would not 
apply to the TGN. Whatever mechanism BFA uses to block 
ER export and disrupt Golgi organization, the apparent in- 
sensitivity of the TGN to BFA action highlights a fundamen- 
tal difference between this compartment and more proximal 
Golgi cisternae. 
Unlike  the  cis-,  medial,  and  trans-Golgi  cisternae,  the 
TGN functions to sort proteins into distinct classes of trans- 
port vesicles, bound for prelysosomes (10),  secretory stor- 
age granules (44), and specific domains of the plasma mem- 
brane  (14,  36).  The  TGN  is  the  site  to  which  man6P 
receptors recycle (10, 17, 26, 35), and where viral glycopro- 
teins accumulate at 20°C (24, 41). The TGN is also a much 
more extended and tubular  structure  than the other Golgi 
cisternae, and thus, it is distinguished by its unique morpho- 
logical  characteristics.  Despite  numerous  distinctions  be- 
tween the TGN and other Golgi cisternae, it is likely that the 
TGN is nevertheless, an integral part of the Golgi complex. 
Grifliths et al. (25) have shown that the TGN and more prox- 
imal Golgi cisternae are highly interrelated  structures.  At 
20°C,  the TGN increases  in size,  concomitant  with a de- 
crease in size of preceding Golgi compartments (25). In ad- 
dition, these workers have calculated that 12% of the TGN 
surface area  is comprised of flattened  cisternae which are 
morphologically  indistinguishable  from,  and  located  im- 
mediately adjacent to, the other cisternae of the Golgi stack. 
Thus, although the TGN is functionally distinct from other 
Golgi  cisternae  (21),  it  is appropriate  to consider  it as  a 
specialized subcompartment of the Golgi complex. An im- 
portant future challenge will be to elucidate the mechanism 
by which the TGN gains (and maintains)  its identity. 
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